Dogs given a single oral dose of bromethalin at 6.25 mg/kg developed a toxic syndrome characterized by hyperexcitability, tremors, seizures, depression, and death within 15-63 hours after bromethalin administration. Gross lesions included mild cerebral edema (2/5) and mild pulmonary congestion (2/5). Histologic lesions included diffuse white matter spongiosis (5/5), mild microgliosis (3/5), optic nerve vacuolization (3/5), mild thickening of Bowman's capsule (2/5), and occasional splenic megakaryocytes (2/5). Ultramicroscopic examination of midbrain stem revealed occasional swollen axons, intramyelinic vacuolization, and myelin splitting at the intraperiod line. Bromethalin was detected in kidney, liver, fat, and brain tissues, using gas chromatography with electron capture detection. Photodegradation of extracted bromethalin may limit accurate quantification of tissue residues.
Acute, single-feeding rodenticides containing 0.01% bromethalin were introduced in 1985. a,b,c Bromethalinbased rodenticides are pelleted (tan or green color) grainbased products that contain 0.75-1.5 ounces (21-42 g) of bait in paper "place pack" enve1opes. l In the exposed animal, bromethalin is N-demethylated by hepatic microsomal enzymes (cytochrome P 450 ) to form the desmethylbromethalin metabolite ( Fig. 1 ). 2, 11 The biochemical mechanism of action for bromethalinbased rodenticides differs from anticoagulant and cholecalciferol-based rodenticides and involves the uncoupling of oxidative phosphorylation. 2, 11, 12 Oxidative phosphorylation is dependent upon the normal function of mitochondria1 cytochromes and is the primary means of ATP production in nervous tissues. Uncoupling of oxidative phosphorylation by bromethalin and desmethylbromethalin, therefore, results in a lack of adequate ATP production and disruption of ATP dependent Na+-K+ ion channel pumps. 11 Disruption of normal ion pump activity in the central nervous system results in the development of cerebral edema and elevated cerebrospinal fluid pressure (CSFP). Additionally, brain and spinal cord moisture and cation concentrations are elevated in rats given a lethal oral dose of bromethalin. 11 The reported oral LD 50 of technical grade brometha-lin ranges from 1.8 mg/kg in the cat to 4.7 mg/kg in the dog to 13 mg/kg in rabbits to > 1,000 mg/kg in guinea pigs. 11 The toxic syndrome produced by bromethalin is dose dependent. 3, 11 Animals that ingest an oral dose of bromethalin at or above the LD 50 generally develop clinical signs within 24 hours. Ingestion of large doses of bromethalin often produces a convulsant syndrome that is characterized by severe muscle tremors, hyperthermia, extreme hyperexcitability, and focal motor and generalized seizures. Conversely, the ingestion of lower doses (less than an LD 50 of bait) induces a toxic syndrome with a slow onset of clinical signs (e.g., 1-5-day onset interval). The delayed syndrome induced by bromethalin is characterized by the development of hind limb ataxia and/or paresis and/ or central nervous system (CNS) depression. In a recently reported feline case of suspected bromethalin poisoning, the cat displayed progressive ataxia, depression, extensor rigidity, and opisthotonus. 7 Bromethalin toxicosis, therefore, may mimic a wide range of clinical syndromes (e.g., other convulsive syndromes, spinal cord injuries, cerebral trauma) and currently poses a significant diagnostic dilemma. This paper presents an analytical method for bromethalin and desmethylbromethalin and describes the histologic lesions induced by bromethalin and/or its desmethyl metabolite in the dog.
Materials and methods
The experimental protocol was reviewed for animal use and welfare and was accepted by the Laboratory Animal Use Committee of the University of Illinois. Random source adult beagle-type dogs obtained from local suppliers were used. Dogs were housed in individual stainless-steel cages and were given free choice water before dosing. Animals were fed a icrosoma1 metabolism of balanced commercial ration, which was available free choice for 1 hr/day. Food was withheld for 12 hr prior to dosing. Dogs were vaccinated with a canine rabies, distemper, infectious hepatitis, parvovirus, adenovirus, and leptospirosis vaccine. Animals were negative for heartworm using a modified Knotts technique. Prior to entry into the study, animals were dewormed and given complete physical and neurologic examinations. Complete blood counts and routine clinical chemistries and serum enzyme activities were determined for all animals 2 days before dosing. Animals were euthanized with an intravenous overdose of pentobarbital.
Ten male beagle-type dogs 2-6 yr of age and 8.6-14.4 kg body weight were used. Animals were assigned equally to bait vehicle (no bromethalin) and bromethalin treatment groups. The dose of bromethalin was 6.25 mg/kg, which was given in the form of pulverized commercially available bait material (25% of the administered dose) in combination with 10% technical grade material in xylene (75% of the administered dose). a,d Before administration of the final bait mixture, technical grade material was added to pulverized bait, the xylene allowed to evaporate (100% evaporation occurred based upon weight changes), and the materials were mixed. An equivalent volume of bait vehicle only (no bromethalin) was presented to control animals.
Serial neurologic and physical examinations were performed every 12 hr on all animals. Animals were monitored continuously for the development of clinical signs for 2 hr after dosing. Animals were then monitored at 30-min intervals for 4 hr and then at 8, 12, 18, 24, 36, and 48 hr postdosing. Animals that displayed clinical signs were monitored Table 1 . Mean (and range) bromethalin and desmethylbromethalin concentrations (ng/g wet weight) detected from tissue samples from dogs (n = 5) given 6.25 mg/kg bromethalin. and examined more frequently. Animals that displayed paresis or paralysis were placed in padded cages. Diazepam e (5-10 mg IV as needed) and/or phenobarbital f (5-15 mg/kg IV as needed) were administered to abolish seizure activity. Euthanasia was performed if an animal displayed severe or persistent seizures (> 15 min of persistent seizure activity) or if paralysis was present for 24 hr or more.
A necropsy was performed on each animal, and tissues collected for histologic examination were placed into formalin. Spinal cord and peripheral nerves were prepared in cross and longitudinal sections. Only cross sections of the brain were prepared. Tissues were prepared by standard procedures, mounted in paraffin, and sections (5 µm) stained with hematoxylin and eosin (HE) for routine evaluation. Areas examined included brain (cerebrum, cerebellum, and brain stem), spinal cord (C2, C7, T-L junction, and L4), peripheral nerves (right sciatic, tibial, and lateral plantar), kidney, liver, lung, heart, adrenal, pancreas, gonad, and spleen. Eyes were routinely fixed in Bouin's for 24 hr and then stored in 10% ethanol until sectioning. Tissues for electron microscopy (2 dogs from each group) were fixed immediately by immersion in 2.5% phosphate-buffered glutaraldehyde. These tissues were postfixed in osmium tetroxide, dehydrated, and embedded in epon. Ultrathin sections (silver interference), stained with uranyl acetate and lead acetate, were examined by transmission electron microscopy.
Liver, kidney, brain, and abdominal fat tissues were collected for chemical analysis from each dog given bromethalin. Samples were stored at -20 C until analysis was performed. Samples (5.0 g) were homogenized (5 min) in 10 ml toluene. Trifluralin or 4,4'-dibromobiphenyl was added as an internal standard to give a final concentration of 200 pg/ µ1 internal standard. After homogenization, samples were then centrifuged (5 min at 3,000 x g) and the supernatant collected. Supernatant (5 ml) from liver, kidney, and brain were then added to a commercially available extraction column, g and the analytes extracted with 2 6-ml volumes of pesticide-grade toluene. The eluates were collected (4-6 ml final volume) and evaporated to dryness under nitrogen. The volume was readjusted to 1 ml with toluene for analysis by capillary column gas chromatography with electron capture detection (GC-ECD). Fat sample extracts were refrigerated for 12 hr, and solvent removed from congealed fat droplets. A gas chromatogram (GC) equipped with a 15-m x 1.5-µm column was used. h,i Temperatures were as follows: injector, 250 C; detector, 375 C; column oven, 200 C, hold time 5 min programmed to 240 C at 25 C/min with a hold time of 15 min. The carrier gas (argon/5% methane) flow was 10 ml/ min. Argon/S% methane makeup gas was added to obtain a total flow of 60 ml/min. These conditions produced the following retention times: trifluralin, 3.5 min; bromethalin, 11.7-12.1 min; and desmethylbromethalin, 16.0-16.5 min. Analytical standards of bromethalin and desmethylbromethalin (each 99.0% pure confirmed by GC-ECD) were donated> Analytical grade (EPA standard) trifluralin (4,4'-dibromooctafluorobiphenyl) was used as an internal standard for liver and kidney extracts. Analytical grade (EPA standard) 4,4'dibromobiphenyl was used in fat and brain extracts. Bromethalin and desmethylbromethalin standards (5-100 pg/µl) in toluene were analyzed by GC-ECD to determine a standard curve. Liver, kidney, brain, and fat samples (5.0 g) containing 5-100 ng bromethalin and desmethylbromethalin/gram wet tissue weight were similarly spiked with internal standard, extracted, and analyzed. Photodegradation studies involved the irradiation of 10-15 µg of bromethalin and desmethylbromethalin (analytical standard) in 10 ml toluene using a Pyrex glass test tube and a 75-watt incandescent light (30-cm light path).
Results
Animals given bromethalin at 6.25 mg/kg developed clinical signs within 6.5-8 hours of dosing. The toxic syndrome was characterized by hyperexcitability, severe muscle tremors, occasional running fits characterized by rapid circling, focal motor and generalized seizures, hind limb hyperreflexia, mild to severe depression, and death. Death occurred between 15 and 63 hours (mean = 30.2 hours) after bromethalin administration. A complete description of the toxic syndrome produced by bromethalin is reported elsewhere. 3 Gross lesions, including mild cerebral edema evidenced by flattening of gyri and narrowing of sulci, were observed in 215 dogs given bromethalin. Mild pulmonary congestion was present in 2/5 dogs that died 40-63 hours after bromethalin administration. The predominant histologic change in all brains from bromethalin-treated dogs was diffuse spongiosis of the white matter due to the presence of numerous, variably sized vacuoles (Fig. 2) . Mild microgliosis was diffusely present in the cerebellum and cerebrum of 3/5 dogs ( Fig. 3) . Mild optic nerve vacuolization was observed in 3/5 dogs (Fig. 4 ). Ultramicroscopic examination of midbrain stem revealed occasional swollen axons, intramyelinic vacuolization, and myelin splitting at the intraperiod line, (Fig. 5 ). Glomerular changes characterized by mild thickening of Bowman's capsule was observed in 2/5 dogs. Occasional megakaryocytes were also observed in splenic tissue from 2/5 dogs.
Bromethalin was detected in kidney, liver, fat, and brain tissues from dogs given bromethalin 15-63 hours earlier (Table 1) . Extraction efficiencies for bromethalin and desmethylbromethalin ranged from 65 to 85% in all tissues. Photodegradation experiments resulted in a 3% loss of bromethalin following 1 hour of irradiation with a 75-watt incandescent lamp. A 50% decrease in bromethalin concentration due to photodegradation, however,. occurred within 2-3 hours. Bromethalin was not detected after 7-8 hours of irradiation. Desmethylbromethalin was minimally photoactive with less than a 10% loss during 8 hours of irradiation. 
Discussion
ducing syndromes (e.g., idiopathic epilepsy). Additionally, bromethalin may also induce a paralytic syn-Bromethalin toxicosis must be considered as a podrome that must be differentiated from other syndromes tential differential diagnosis for neurologic syndromes (e.g., trauma, spinal cord neoplasia, etc.) that also procharacterized by the development of seizures, tremors, duce paralysis. hyperactivity/hyperexcitability, hind limb paresis, pa-Bromethalin administration to dogs and rats has been ralysis, and progressive central nervous system depresreported to produce an increase in cerebrospinal fluid sion. Bromethalin toxicosis, therefore, may resemble pressure. 2, 3, 11 Brain and spinal cord water content and poisonings induced by convulsant toxins (e.g., lead, cation concentrations are also elevated in rats given a sodium fluoroacetate [compound 1080], strychnine, lethal oral dose of bromethalin. 2, 11 The presence of organochlorine insecticides, etc.) and other seizure promild splenic extramedullary hematopoesis and glo- merular capsular thickening observed in 2 dogs may be incidental findings and are not considered diagnostic for bromethalin toxicosis. Lesions of the CNS, however, were observed in all bromethalin-dosed dogs and were considered supportive of a diagnosis. Gross evidence of cerebral edema was considered mild in bromethalin-poisoned dogs. Diffuse white matter vacuolization (spongy degeneration) with mild microgliosis was the most characteristic histologic lesion and is similar to previously reported lesions. 7, 11 Vacuolization of the optic nerve also occurred and may partially account for the loss of menace response and abnormal pupillary light reflexes observed in several dogs. Ultrastructurally, large distinct intramyelinic vacuoles were identified in brain stem neurons. The morphologic and ultrastructural findings in this study are similar to those reported for other toxic causes of spongy degeneration, such as trialkyl tin, hexachlorophene, isoniazid, and Cuprizone (biscyclohexanone oxalyldihydrazone) 6, 8, 9, 13 Similar to bromethalin, hexachlorophene . and triethyltin induce widespread edema of the CNS white matter by forming intramyelinic vacuoles that are due to separation of myelin sheaths at the intraperiod line. 4, 5 Optic nerve vacuo lization has also been reported in hexachlorophene toxicosis. 10 Congenital spongiform leucoencephalopathies have also been reported to produce intramyelinic vacuolization. 14 Chemical confirmation of bromethalin residues may have limited clinical utility in cases in which a delay in presentation (i.e., the chronic syndrome) occurs. Accurate quantification of bromethalin in tissues is limited by the rapid photodegradation of bromethalin in sample extracts. Although efforts were taken to limit photodegradation (use of red lights, rapid chromatographic analysis), some imprecision in the bromethalin concentrations reported in this study would be expected. Therefore, the toxicologic significance of the bromethalin and desmethylbromethalin concentrations detected in these experimental tissue samples is questionable. Exposure to bromethalin, however, can be confirmed by chemical analysis of tissues. Other tissues in which bromethalin can be detected include serum, urine, and stomach contents.
The diagnosis of bromethalin poisoning is dependent upon the presence of an exposure history to a potentially toxic dose of a bromethalin-based rodenticide, clinical signs, histologic lesions characterized by white matter vacuolization and gliosis, intramyelinic vacuolization, and, when available, detection of bromethalin or desmethylbromethalin in tissue residues. 1 
